Frédéric Leduc, PhD

CEO, Immune Biosolutions, Inc

Address

Research interest

  • Therapeutic and diagnostic antibody discovery for difficult targets
  • Development of nutraceutical chicken antibodies
  • Development of new technologies in the field of reproductive biology

Immune Biosolutions (IBio) is an innovative biotech company focused on the discovery and engineering of chicken edible and recombinant antibodies with a recognized, yet unexploited, therapeutic potential.  Our focus is to change the odds of antibody discovery against traditionally difficult target, such as GPCRs and other membranes proteins.

Members of the laboratory

Simon Gaudreau, PhD
CSO
sgaudreau@ibiosolutions.com

Jean-François Larrivée, PhD
COO
jlarrivee@ibiosolutions.com

Yolaine Robitaille, MSc, MBA
BD Director
yrobitaille@ibiosolutions.com

Steeve Véronneau, MSc
Administrative Scientist
sveronneau@ibiosolutions.com

Martin Cloutier, MSc
Administrative Scientist
mcloutier@ibiosolutions.com

Djordje Grbic, PhD
Senior Scientist and Project Leader
dgrbic@ibiosolutions.com

Maryse Thivierge, PhD
Senior Scientist and Project Leader
mthivierge@ibiosolutions.com

Alexandre Fugère, MSc
Scientist
afugere@ibiosolutions.com

Claudia Pavel, Ing
Scientist
cpavel@ibiosolutions.com

Nadiia Shkilna, MSc
Scientist
nshkilna@ibiosolutions.com

Jennifer Lafontaine, MSc
Postdoc
marie-edith.nepveu- traversy@usherbrooke.ca

Publications

SEE SCOPUS